What is the biosimilar book commonly referred to as?

Study for the FIPA 2 Exam 3. Hone your skills with flashcards and multiple choice questions, each question with hints and explanations. Prepare for your exam confidently!

Multiple Choice

What is the biosimilar book commonly referred to as?

Explanation:
The main idea is recognizing that the FDA maintains a registry of licensed biological products, including biosimilars and their reference products, which is commonly called the Purple Book. This resource lists which products have been licensed, identifies biosimilarity and interchangeability determinations, and notes exclusivity dates. It’s the standard nickname for the FDA’s list of biosimilars, much like the Orange Book serves for small-molecule drugs. So, when people refer to the biosimilar book, they’re usually pointing to the Purple Book.

The main idea is recognizing that the FDA maintains a registry of licensed biological products, including biosimilars and their reference products, which is commonly called the Purple Book. This resource lists which products have been licensed, identifies biosimilarity and interchangeability determinations, and notes exclusivity dates. It’s the standard nickname for the FDA’s list of biosimilars, much like the Orange Book serves for small-molecule drugs. So, when people refer to the biosimilar book, they’re usually pointing to the Purple Book.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy